+64 7 839 4771

Life Sciences & Biotechnology

Our Life Sciences and Biotechnology practice advise some of the world’s largest pharmaceutical, and animal health companies providing guidance, insight, and advice on all aspects of their operations. We use a multi-disciplinary team approach across the firm to deliver innovative and value-enhancing solutions.

Our work includes advising on clinical trials, consultancy arrangements, the supply of medicines prior to registration, the New Zealand medicines registration process, privately funded medicines, government funding arrangements with PHARMAC and DHBs, import, export, licencing, agency and distribution arrangements, advertising review and vetting advice, pharmacovigilance issues and the handling of adverse events and product recalls.

We have also advised clients on nutraceuticals, health food products, natural medicines, vitamin supplements, medical devices, and animal remedies.

We work with start-ups and new ventures in the biotechnology area, including on the sourcing of funding from private equity, charities, and government and on the marketing and licencing of innovative products, both in New Zealand and overseas.

Areas of expertise:

  • Commercialisation of Intellectual Property
  • Private Equity
  • Venture Capital
  • Commercial Disputes
  • Intellectual Property litigation
  • Intellectual Property protection and development
  • Research and Pharmacovigilence

Life Sciences & Biotechnology team

Kate Cornegé

Partner

Robert Bycroft

Special Counsel

Shelley Slade-Gully

Senior Associate

Tina Liu

Associate